Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9323344rdf:typepubmed:Citationlld:pubmed
pubmed-article:9323344lifeskim:mentionsumls-concept:C0162429lld:lifeskim
pubmed-article:9323344lifeskim:mentionsumls-concept:C1457887lld:lifeskim
pubmed-article:9323344lifeskim:mentionsumls-concept:C0015392lld:lifeskim
pubmed-article:9323344lifeskim:mentionsumls-concept:C0036341lld:lifeskim
pubmed-article:9323344lifeskim:mentionsumls-concept:C0205160lld:lifeskim
pubmed-article:9323344lifeskim:mentionsumls-concept:C0011155lld:lifeskim
pubmed-article:9323344lifeskim:mentionsumls-concept:C0546881lld:lifeskim
pubmed-article:9323344pubmed:issue2-3lld:pubmed
pubmed-article:9323344pubmed:dateCreated1998-1-6lld:pubmed
pubmed-article:9323344pubmed:abstractTextThirty patients with a DSM-III-R diagnosis of schizophrenia were assessed for severity of schizophrenic symptoms using the Brief Psychiatric Rating Scale (BPRS) and were tested on a Continuous Performance Test (CPT) and a smooth pursuit eye tracking task. Negative symptoms were significantly correlated with eye tracking impairment (r = 0.43, p < 0.01) and CPT deficits (r = 0.67, p < 0.001), but performance on neither task was correlated with positive symptoms. CPT performance and eye tracking performance were modestly correlated with each other (r = 0.39, p < 0.01) and CPT performance was found to be a stronger predictor of negative symptoms than eye tracking performance. These data indicate that neurocognitive markers of vulnerability to schizophrenia are associated with negative rather than positive symptoms.lld:pubmed
pubmed-article:9323344pubmed:languageenglld:pubmed
pubmed-article:9323344pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9323344pubmed:citationSubsetIMlld:pubmed
pubmed-article:9323344pubmed:statusMEDLINElld:pubmed
pubmed-article:9323344pubmed:monthAuglld:pubmed
pubmed-article:9323344pubmed:issn0920-9964lld:pubmed
pubmed-article:9323344pubmed:authorpubmed-author:MohsR CRClld:pubmed
pubmed-article:9323344pubmed:authorpubmed-author:SieverL JLJlld:pubmed
pubmed-article:9323344pubmed:authorpubmed-author:HarveyP DPDlld:pubmed
pubmed-article:9323344pubmed:authorpubmed-author:KeefeR SRSlld:pubmed
pubmed-article:9323344pubmed:authorpubmed-author:RoitmanS ESElld:pubmed
pubmed-article:9323344pubmed:issnTypePrintlld:pubmed
pubmed-article:9323344pubmed:day29lld:pubmed
pubmed-article:9323344pubmed:volume26lld:pubmed
pubmed-article:9323344pubmed:ownerNLMlld:pubmed
pubmed-article:9323344pubmed:authorsCompleteYlld:pubmed
pubmed-article:9323344pubmed:pagination139-46lld:pubmed
pubmed-article:9323344pubmed:dateRevised2010-9-2lld:pubmed
pubmed-article:9323344pubmed:meshHeadingpubmed-meshheading:9323344-...lld:pubmed
pubmed-article:9323344pubmed:meshHeadingpubmed-meshheading:9323344-...lld:pubmed
pubmed-article:9323344pubmed:meshHeadingpubmed-meshheading:9323344-...lld:pubmed
pubmed-article:9323344pubmed:meshHeadingpubmed-meshheading:9323344-...lld:pubmed
pubmed-article:9323344pubmed:meshHeadingpubmed-meshheading:9323344-...lld:pubmed
pubmed-article:9323344pubmed:meshHeadingpubmed-meshheading:9323344-...lld:pubmed
pubmed-article:9323344pubmed:meshHeadingpubmed-meshheading:9323344-...lld:pubmed
pubmed-article:9323344pubmed:meshHeadingpubmed-meshheading:9323344-...lld:pubmed
pubmed-article:9323344pubmed:meshHeadingpubmed-meshheading:9323344-...lld:pubmed
pubmed-article:9323344pubmed:year1997lld:pubmed
pubmed-article:9323344pubmed:articleTitleAttentional and eye tracking deficits correlate with negative symptoms in schizophrenia.lld:pubmed
pubmed-article:9323344pubmed:affiliationDepartment of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA.lld:pubmed
pubmed-article:9323344pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9323344pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9323344lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9323344lld:pubmed